391 related articles for article (PubMed ID: 12963568)
1. Clinical spectrum and prevalence of neurologic events provoked by tilt table testing.
Passman R; Horvath G; Thomas J; Kruse J; Shah A; Goldberger J; Kadish A
Arch Intern Med; 2003 Sep; 163(16):1945-8. PubMed ID: 12963568
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of intravenous metoprolol during positive isoproterenol tilt-table test in the choice of treatment for neurocardiogenic syncope.
Baran I; Gemici K; Ozdemir B; Saraç M; Güllülü S; Aydinlar A; Cordan J
Indian Heart J; 2003; 55(1):40-3. PubMed ID: 12760586
[TBL] [Abstract][Full Text] [Related]
3. [Sensitization of tilt-table testing for syncope of unknown etiology: which drug to use?].
Salamé E; Neemtallah R; Azar R; Antonios S; Jazra C; Kassab R
Ann Cardiol Angeiol (Paris); 2006 Jun; 55(3):135-9. PubMed ID: 16792028
[TBL] [Abstract][Full Text] [Related]
4. The value of tilt table testing with isoproterenol in determining therapy in adults with syncope and presyncope of unexplained origin.
Tonnessen GE; Haft JI; Fulton J; Rubenstein DG
Arch Intern Med; 1994 Jul; 154(14):1613-7. PubMed ID: 8031209
[TBL] [Abstract][Full Text] [Related]
5. Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope.
Cox MM; Perlman BA; Mayor MR; Silberstein TA; Levin E; Pringle L; Castellanos A; Myerburg RJ
J Am Coll Cardiol; 1995 Nov; 26(5):1293-8. PubMed ID: 7594046
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility of nitrate-stimulated tilt testing in patients with suspected vasovagal syncope and a healthy control group.
Aerts AJ; Dendale P; Block P; Dassen WR
Am Heart J; 2005 Aug; 150(2):251-6. PubMed ID: 16086926
[TBL] [Abstract][Full Text] [Related]
7. Tilt test in elderly patients with syncope of unknown etiology: experience with pharmacological stimulation with nitroglycerin.
Timóteo AT; Oliveira MM; Antunes E; Vieira AP; Feliciano J; Fiarresga AJ; Silva S; Coito S; Quininha J
Rev Port Cardiol; 2005; 24(7-8):945-53. PubMed ID: 16240681
[TBL] [Abstract][Full Text] [Related]
8. Head-up tilt table testing in syncope: safety and efficiency of isosorbide versus isoproterenol in pediatric population.
Swissa M; Epstein M; Paz O; Shimoni S; Caspi A
Am Heart J; 2008 Sep; 156(3):477-82. PubMed ID: 18760129
[TBL] [Abstract][Full Text] [Related]
9. [Importance of tilt-table testing compared with Schellong's test for the diagnosis of orthostatic dysregulations/syncopes].
Jungblut S; Frickmann H; Römer A; Gilfrich HJ
Med Klin (Munich); 2006 Mar; 101(3):198-202. PubMed ID: 16648976
[TBL] [Abstract][Full Text] [Related]
10. Value of propranolol-induced heart rate and blood pressure changes in predicting results of tilt testing.
Gielerak G; Kozłowski D; Dłuzniewska E; Roszczyk A; Cholewa M
Kardiol Pol; 2003 Feb; 58(2):98-108. PubMed ID: 14504635
[TBL] [Abstract][Full Text] [Related]
11. Provocation of neurocardiogenic syncope during head-up tilt testing in children: comparison between isoproterenol and nitroglycerin.
Vlahos AP; Tzoufi M; Katsouras CS; Barka T; Sionti I; Michalis LK; Siamopoulou A; Kolettis TM
Pediatrics; 2007 Feb; 119(2):e419-25. PubMed ID: 17224456
[TBL] [Abstract][Full Text] [Related]
12. [Tilt-table study in vasovagal syncope. The diagnostic gain from isoprenaline administration].
Bräuninger S; Maas A; Nanke C; Stellwaag M; Uebis S; Lambertz H
Dtsch Med Wochenschr; 1996 Aug; 121(31-32):971-7. PubMed ID: 8765400
[TBL] [Abstract][Full Text] [Related]
13. [Value of the tilt-table test in the management of unexplained syncope in children and adolescents].
Kouakam C; Vaksmann G; Lacroix D; Godart F; Kacet S; Rey C
Arch Mal Coeur Vaiss; 1997 May; 90(5):679-86. PubMed ID: 9295951
[TBL] [Abstract][Full Text] [Related]
14. Frequency of arrhythmic events during head-up tilt testing in patients with suspected neurocardiogenic syncope or presyncope.
Kim PH; Ahn SJ; Kim JS
Am J Cardiol; 2004 Dec; 94(12):1491-5. PubMed ID: 15589002
[TBL] [Abstract][Full Text] [Related]
15. [Use of tilt test in the investigation of syncope].
Aksnes TA; Nodenes K; Gjesdal K
Tidsskr Nor Laegeforen; 2000 Mar; 120(7):803-6. PubMed ID: 10806903
[TBL] [Abstract][Full Text] [Related]
16. Age and gender differences in basal and isoprenaline protocols for head-up tilt table testing.
Barón-Esquivias G; Pedrote A; Cayuela A; Valle JI; Fernández JM; Estepa MJ; Martínez-Morentín E; Navarro M; Burgos J
Europace; 2001 Apr; 3(2):136-40. PubMed ID: 11333051
[TBL] [Abstract][Full Text] [Related]
17. Head-up tilt table testing with low dose sublingual isosorbide dinitrate in the evaluation of unexplained syncope: a comparison with isoproterenol infusion.
Aslan O; Guneri S; Badak O; Kirimli O; Goldeli O; Keskin V; Akdeniz B; Tekin U
Can J Cardiol; 2002 Aug; 18(8):853-9. PubMed ID: 12215748
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of tilt training in patients with vasovagal syncope.
Gajek J; Zyśko D; Mazurek W
Kardiol Pol; 2006 Jun; 64(6):602-8; discussion 609-10. PubMed ID: 16810579
[TBL] [Abstract][Full Text] [Related]
19. Formal analysis of the optimal duration of tilt testing for the diagnosis of neurally mediated syncope.
Stein KM; Slotwiner DJ; Mittal S; Scheiner M; Markowitz SM; Lerman BB
Am Heart J; 2001 Feb; 141(2):282-8. PubMed ID: 11174344
[TBL] [Abstract][Full Text] [Related]
20. The usefulness of tilt testing with an intravenous beta-blocker in assessing the efficacy of long-term therapy in patients with vasovagal syncope.
Gielerak G; Makowski K; Dłuzniewska E; Stec A; Cholewa M
Kardiol Pol; 2003 Aug; 59(8):93-104; commentary 103-4. PubMed ID: 14560324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
